BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 15588104)

  • 1. Structural consequences of D481N/K483Q mutation at glycine binding site of NMDA ionotropic glutamate receptors: a molecular dynamics study.
    Blaise MC; Bhattacharyya D; Sowdhamini R; Pradhan N
    J Biomol Struct Dyn; 2005 Feb; 22(4):399-410. PubMed ID: 15588104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Model structures of the N-methyl-D-aspartate receptor subunit NR1 explain the molecular recognition of agonist and antagonist ligands.
    Moretti L; Pentikäinen OT; Settimo L; Johnson MS
    J Struct Biol; 2004 Mar; 145(3):205-15. PubMed ID: 14960371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolutionary trace analysis of ionotropic glutamate receptor sequences and modeling the interactions of agonists with different NMDA receptor subunits.
    Blaise MC; Sowdhamini R; Rao MR; Pradhan N
    J Mol Model; 2004 Dec; 10(5-6):305-16. PubMed ID: 15597199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural features of the glutamate binding site in recombinant NR1/NR2A N-methyl-D-aspartate receptors determined by site-directed mutagenesis and molecular modeling.
    Chen PE; Geballe MT; Stansfeld PJ; Johnston AR; Yuan H; Jacob AL; Snyder JP; Traynelis SF; Wyllie DJ
    Mol Pharmacol; 2005 May; 67(5):1470-84. PubMed ID: 15703381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of activation, inhibition and specificity: crystal structures of the NMDA receptor NR1 ligand-binding core.
    Furukawa H; Gouaux E
    EMBO J; 2003 Jun; 22(12):2873-85. PubMed ID: 12805203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular determinants of ligand discrimination in the glutamate-binding pocket of the NMDA receptor.
    Laube B; Schemm R; Betz H
    Neuropharmacology; 2004 Dec; 47(7):994-1007. PubMed ID: 15555634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe impairment of NMDA receptor function in mice carrying targeted point mutations in the glycine binding site results in drug-resistant nonhabituating hyperactivity.
    Ballard TM; Pauly-Evers M; Higgins GA; Ouagazzal AM; Mutel V; Borroni E; Kemp JA; Bluethmann H; Kew JN
    J Neurosci; 2002 Aug; 22(15):6713-23. PubMed ID: 12151550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterisation of the human NMDA receptor subunit NR3A glycine binding site.
    Nilsson A; Duan J; Mo-Boquist LL; Benedikz E; Sundström E
    Neuropharmacology; 2007 Mar; 52(4):1151-9. PubMed ID: 17320117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of amino acids in the N-methyl-D-aspartate receptor NR1 subunit that contribute to the glycine binding site.
    Wafford KA; Kathoria M; Bain CJ; Marshall G; Le Bourdellès B; Kemp JA; Whiting PJ
    Mol Pharmacol; 1995 Feb; 47(2):374-80. PubMed ID: 7870047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of different competitive antagonists interaction with NR2A and NR2B subunits of N-methyl-D-aspartate (NMDA) ionotropic glutamate receptor.
    Blaise MC; Sowdhamini R; Pradhan N
    J Mol Model; 2005 Nov; 11(6):489-502. PubMed ID: 15928921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactive affinity probes for the mapping of the glycine-binding site of the NMDA receptor NR1 subunit.
    Kreimeyer A; Laube B; Sturgess M; Goeldner M; Foucaud B
    J Recept Signal Transduct Res; 1999; 19(1-4):547-57. PubMed ID: 10071784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and characterization of a glycine-binding fragment of the N-methyl-D-aspartate receptor subunit NR1.
    Miyazaki J; Nakanishi S; Jingami H
    Biochem J; 1999 Jun; 340 ( Pt 3)(Pt 3):687-92. PubMed ID: 10359652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a soluble ligand binding domain of the NMDA receptor regulatory subunit NR3A.
    Yao Y; Mayer ML
    J Neurosci; 2006 Apr; 26(17):4559-66. PubMed ID: 16641235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of N-methyl-D-aspartate receptors by glycine: role of an aspartate residue in the M3-M4 loop of the NR1 subunit.
    Williams K; Chao J; Kashiwagi K; Masuko T; Igarashi K
    Mol Pharmacol; 1996 Oct; 50(4):701-8. PubMed ID: 8863813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-methyl-D-aspartate receptors: different subunit requirements for binding of glutamate antagonists, glycine antagonists, and channel-blocking agents.
    Lynch DR; Anegawa NJ; Verdoorn T; Pritchett DB
    Mol Pharmacol; 1994 Mar; 45(3):540-5. PubMed ID: 7511781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tweaking agonist efficacy at N-methyl-D-aspartate receptors by site-directed mutagenesis.
    Hansen KB; Clausen RP; Bjerrum EJ; Bechmann C; Greenwood JR; Christensen C; Kristensen JL; Egebjerg J; Bräuner-Osborne H
    Mol Pharmacol; 2005 Dec; 68(6):1510-23. PubMed ID: 16131614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An acidic amino acid in the N-methyl-D-aspartate receptor that is important for spermine stimulation.
    Williams K; Kashiwagi K; Fukuchi J; Igarashi K
    Mol Pharmacol; 1995 Dec; 48(6):1087-98. PubMed ID: 8848009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The function of the amino terminal domain in NMDA receptor modulation.
    Huggins DJ; Grant GH
    J Mol Graph Model; 2005 Jan; 23(4):381-8. PubMed ID: 15670959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural dynamics of the glycine-binding domain of the N-methyl-D-aspartate receptor.
    Dolino DM; Cooper D; Ramaswamy S; Jaurich H; Landes CF; Jayaraman V
    J Biol Chem; 2015 Jan; 290(2):797-804. PubMed ID: 25404733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and initial characterization of a soluble glycine binding domain of the N-methyl-D-aspartate receptor NR1 subunit.
    Ivanovic A; Reiländer H; Laube B; Kuhse J
    J Biol Chem; 1998 Aug; 273(32):19933-7. PubMed ID: 9685327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.